Clinical Trial Update: A Study of Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative Pain Associated With Orthopedic Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Combogesic 325 in adolescents with postoperative orthopedic pain is planned. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Combogesic 325

Snippet

Sponsor: AFT Pharmaceuticals, Ltd. | Conditions: Post Operative Pain, Acute | Phase 3 | Status: NOT_YET_RECRUITING